Experience

C4X Discovery Ltd

• United Kingdom
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Operating Officer

  • Feb 2022 - Present

  C4X Discovery (“C4XD”) is a pioneering Drug Discovery company combining scientific expertise with cutting-edge Drug Discovery technologies to efficiently deliver world leading medicines, which are developed by our partners for the benefit of patients. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced DNA-based target identification and candidate molecule design capabilities, generating small molecule drug candidates across multiple disease areas including inflammation, oncology, neurodegeneration and addictive disorders. Our commercially attractive portfolio ranges from early stage novel target opportunities to late stage Drug Discovery programmes ready for out-licensing to partners and we have two commercially partnered programmes with one candidate in clinical development.We collaborate with leading pharmaceutical and life sciences companies to enrich our expertise and take our assets through pre-clinical and clinical development. Through early-stage revenue-generating licensing deals, we realise returns from our high value pre-clinical assets which are reinvested to maximise the value of our Drug Discovery portfolio.As part of my role, I oversee operations, governance and policies as well as portfolio management, employee productivity and building on the Company’s highly inclusive culture. Show less

• Vice President Operations

  • Nov 2016 - Feb 2022

• Senior Programme Manager

  • Jan 2014 - Nov 2016

  C4X Discovery is a Manchester-based company focused on optimising drug discovery and design. It was founded in 2008 as a spin-out from the University of Manchester. The company uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. Since C4X Discovery's NMR technology shows what shapes active molecules prefer to adopt, it provides high-quality templates for drug discovery and design, and valuable information for drug candidate optimisation. In addition, the data is generated faster and more reliably than standard techniques such as X-ray co-crystallography or molecular modelling. C4X Discovery is using its technology in collaboration with the pharmaceutical industry and to build its own proprietary pipeline of high-value therapeutic candidates. It has been funded since inception by life science investor Aquarius Equity Partners. www.c4xdiscovery.com . Show less



Peakdale Molecular (Now Concept Life Sciences)

• United Kingdom
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Section Head

  • May 2008 - Dec 2013



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Principal Scientist

  • 2003 - 2008